论文部分内容阅读
目的探析射频消融术与肝动脉化疗栓塞术治疗肝癌的临床效果。方法选取2014年7月~2016年7月我院收治的74例肝癌患者为主要研究对象,根据随机分配的原则将其分为两组,每组37例。A组患者接受射频消融术治疗,B组患者接受肝动脉化疗栓塞术治疗,对两组患者的临床治疗效果进行对比分析。结果 A组的临床治疗有效率为83.78%,与B组的56.76%相比差异有统计学意义(P<0.05);A组患者治疗后的ALB、CHE水平较治疗前明显降低(P<0.05),B组患者的TB、ALT水平明显高于治疗前,且ALB、CHE明显低于治疗前(P<0.05)。结论相对于肝动脉化疗栓塞术,肝癌患者接受射频消融术治疗对其肝功能造成的损害相对较小,且临床治疗有效率更高,可在临床上进一步推广应用。
Objective To investigate the clinical effects of radiofrequency ablation and hepatic artery chemoembolization in the treatment of liver cancer. Methods From July 2014 to July 2016, 74 patients with hepatocellular carcinoma who were admitted to our hospital were selected as the main study subjects. They were divided into two groups according to the principle of random distribution, with 37 patients in each group. Group A patients underwent radiofrequency catheter ablation, Group B patients undergoing transcatheter arterial chemoembolization, and the clinical effects of the two groups were compared. Results The effective rate of clinical treatment in group A was 83.78%, which was significantly lower than that in group B (56.76%, P <0.05). The ALB and CHE levels in group A were significantly lower than those before treatment (P <0.05 ). The levels of TB and ALT in group B were significantly higher than those before treatment, and the levels of ALB and CHE were significantly lower than those before treatment (P <0.05). Conclusions Compared with hepatic arterial chemoembolization, patients with liver cancer undergoing radiofrequency catheter ablation have less damage to liver function and clinical treatment is more efficient and can be further popularized and applied clinically.